Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Baird analyst Wesley Golladay initiated coverage on American Healthcare REIT, Inc. (NYSE:AHR) with an Outperform rating and announced a price target of $41. American Healthcare shares closed at $37.26 on Thursday. See how other analysts view this stock.
• Evercore ISI Group analyst Amit Daryanani initiated coverage on Ralliant Corporation (NYSE:RAL) with an In-Line rating and announced a price target of $52. Ralliant shares closed at $48.02 on Thursday. See how other analysts view this stock.
• Wedbush analyst Alicia Reese initiated coverage on The Marcus Corporation (NYSE:MCS) with an Outperform rating and announced a price target of $24. Marcus shares closed at $17.24 on Thursday. See how other analysts view this stock.
• Jefferies analyst Andrew Tsai initiated coverage on Stoke Therapeutics, Inc. (NASDAQ:STOK) with a Buy rating and announced a price target of $30. Stoke Therapeutics shares closed at $12.35 on Thursday. See how other analysts view this stock.
• Rosenblatt analyst Catharine Trebnick initiated coverage on Verint Systems Inc. (NASDAQ:VRNT) with a Buy rating and announced a price target of $40. Verint shares closed at $20.56 on Thursday. See how other analysts view this stock.

Considering buying MCS stock? Here’s what analysts think:

Read This Next:

• Top 2 Defensive Stocks That Are Ticking Portfolio Bombs

Photo via Shutterstock